ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 720 filers reported holding ISHARES TR in Q4 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $366,870 | -3.7% | 3,000 | 0.0% | 0.08% | -2.3% |
| Q2 2023 | $380,880 | -1.7% | 3,000 | 0.0% | 0.09% | -7.5% |
| Q1 2023 | $387,480 | -1.6% | 3,000 | 0.0% | 0.09% | -7.0% |
| Q4 2022 | $393,870 | +12.2% | 3,000 | 0.0% | 0.10% | +11.1% |
| Q3 2022 | $351,000 | -0.6% | 3,000 | 0.0% | 0.09% | +1.1% |
| Q2 2022 | $353,000 | -9.7% | 3,000 | 0.0% | 0.09% | -2.2% |
| Q1 2022 | $391,000 | -14.6% | 3,000 | 0.0% | 0.09% | -11.7% |
| Q4 2021 | $458,000 | -5.6% | 3,000 | 0.0% | 0.10% | -13.4% |
| Q3 2021 | $485,000 | -1.2% | 3,000 | 0.0% | 0.12% | -4.0% |
| Q2 2021 | $491,000 | +8.6% | 3,000 | 0.0% | 0.12% | -2.4% |
| Q1 2021 | $452,000 | -0.4% | 3,000 | 0.0% | 0.13% | -10.6% |
| Q4 2020 | $454,000 | +11.8% | 3,000 | 0.0% | 0.14% | -0.7% |
| Q3 2020 | $406,000 | -1.0% | 3,000 | 0.0% | 0.14% | -8.3% |
| Q2 2020 | $410,000 | +8.2% | 3,000 | 0.0% | 0.16% | -3.7% |
| Q1 2020 | $379,000 | -0.8% | 3,000 | -3.7% | 0.16% | -0.6% |
| Q4 2019 | $382,000 | – | 3,114 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |